Carl L. G. Hansen Ab Cellera Biologics Inc. (ABCL) insider trading activity

Carl L. G. Hansen is Chief Executive Officer of AbCellera Biologics Inc.. Currently has a direct ownership of 841,875 shares of ABCL, which is worth approximately $2.32 Million. The most recent transaction as insider was on Sep 20, 2024, when has been sold 56,125 shares (Common Shares) at a price of $2.7 per share, resulting in proceeds of $151,537. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 842K

7.14% 3M change

25.0% 12M change

Total Value Held $2.32 Million

Carl L. G. Hansen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 20 2024	BUY Exercise of conversion of derivative security	$151,537 $2.7 p/Share	56,125 Added 6.25%	841,875 Common Shares
May 31 2024	BUY Exercise of conversion of derivative security	$151,537 $2.7 p/Share	56,125 Added 6.67%	785,750 Common Shares
Feb 26 2024	BUY Exercise of conversion of derivative security	$151,537 $2.7 p/Share	56,125 Added 7.14%	729,625 Common Shares
Nov 23 2023	BUY Exercise of conversion of derivative security	$151,537 $2.7 p/Share	56,125 Added 7.69%	673,500 Common Shares
Aug 24 2023	BUY Exercise of conversion of derivative security	$151,537 $2.7 p/Share	56,125 Added 8.33%	617,375 Common Shares
May 26 2023	BUY Exercise of conversion of derivative security	$151,537 $2.7 p/Share	56,125 Added 9.09%	561,250 Common Shares
Feb 22 2023	BUY Exercise of conversion of derivative security	$151,537 $2.7 p/Share	56,125 Added 10.0%	505,125 Common Shares
Nov 18 2022	BUY Exercise of conversion of derivative security	$151,537 $2.7 p/Share	56,125 Added 11.11%	449,000 Common Shares
Aug 18 2022	BUY Exercise of conversion of derivative security	$151,538 $2.7 p/Share	56,125 Added 12.5%	392,875 Common Shares
May 18 2022	BUY Exercise of conversion of derivative security	$151,538 $2.7 p/Share	56,125 Added 14.29%	336,750 Common Shares
Feb 22 2022	BUY Exercise of conversion of derivative security	$151,538 $2.7 p/Share	56,125 Added 16.67%	280,625 Common Shares
Nov 18 2021	BUY Exercise of conversion of derivative security	$3,374,235 $15.03 p/Share	224,500 Added 50.0%	224,500 Common Shares

CLG

Carl L. G. Hansen

Chief Executive Officer

Vancouver, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABCL shares.

Notify only if

Value

Insider Trading

Get notified when an Ab Cellera Biologics Inc. insider buys or sells ABCL shares.

Notify only if

Operation

Value

Type

News

Receive news related to AbCellera Biologics Inc.

Track Activities on ABCL

Account